tiprankstipranks
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
US Market

Collegium Pharmaceutical (COLL) Income Statement

Compare
472 Followers

Collegium Pharmaceutical Income Statement

Last quarter (Q3 2024), Collegium Pharmaceutical's total revenue was $159.30M, an increase of 16.53% from the same quarter last year. In Q3, Collegium Pharmaceutical's net income was $9.34M. See Collegium Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 566.77M$ 463.93M$ 276.87M$ 310.02M$ 296.70M
Gross Profit
$ 326.17M$ 209.49M$ 150.62M$ 179.84M$ 103.04M
Operating Expenses
$ 150.71M$ 176.17M$ 128.41M$ 123.60M$ 126.79M
Depreciation and Amortization
$ 149.26M$ 134.39M$ 68.94M$ 61.61M$ 15.80M
EBITDA
$ 308.33M$ 168.76M$ 86.58M$ 118.07M$ -6.02M
Operating Income
$ 166.96M$ -104.57M$ -46.70M$ -5.09M$ -23.75M
Other Income/Expenses
$ -91.23M$ -62.17M$ -21.00M$ -28.65M$ 1.03M
Pretax Income
$ 75.73M$ -28.85M$ -3.37M$ 27.58M$ -22.72M
Net Income
$ 48.16M$ -25.00M$ 71.52M$ 26.75M$ -8.15M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 1.60$ -0.74$ 2.05$ 0.78$ -0.24
Diluted EPS
$ 1.29$ -0.74$ 1.86$ 0.76$ -0.24
Weighted Average Shares Outstanding
33.74M 33.83M 34.94M 34.41M 33.45M
Weighted Average Shares Outstanding (Diluted)
41.79M 33.83M 41.05M 35.15M 33.45M
Currency in USD

Collegium Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis